Literature DB >> 21777182

The family B1 GPCR: structural aspects and interaction with accessory proteins.

Alain Couvineau1, Marc Laburthe.   

Abstract

G protein coupled receptors (GPCRs) play a crucial role in physiology and pathophysiology in humans. Beside the large family A (rhodopsin-like receptors) and family C GPCR (metabotropic glutamate receptors), the small family B1 GPCR (secretin-like receptors) includes important receptors such as vasoactive intestinal peptide receptors (VPAC), pituitary adenylyl cyclase activating peptide receptor (PAC1R), secretin receptor (SECR), growth hormone releasing factor receptor (GRFR), glucagon receptor (GCGR), glucagon like-peptide 1 and 2 receptors (GLPR), gastric inhibitory peptide receptor (GIPR), parathyroid hormone receptors (PTHR), calcitonin receptors (CTR) and corticotropin-releasing factor receptors (CRFR). They represent very promising targets for the development of drugs having therapeutical impact on many diseases such as chronic inflammation, neurodegeneration, diabetes, stress and osteoporosis. Over the past decade, structure-function relationship studies have demonstrated that the N-terminal ectodomain (N-ted) of family B1 receptors plays a pivotal role in natural ligand recognition. Structural analysis of some family B1 GPCR N-teds revealed the existence of a Sushi domain fold consisting of two antiparallel β sheets stabilized by three disulfide bonds and a salt bridge. The family B1 GPCRs promote cellular responses through a signaling pathway including predominantly the Gsadenylyl cyclase-cAMP pathway activation. Family B1 GPCRs also interact with a few accessory proteins which play a role in cell signaling, receptor expression and/or pharmacological profiles of receptors. These accessory proteins may represent new targets for the design of new drugs. Here, we review the current knowledge regarding: i) the structure of family B1 GPCR binding domain for natural ligands and ii) the interaction of family B1 GPCRs with accessory proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21777182     DOI: 10.2174/138945012798868434

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  22 in total

Review 1.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells.

Authors:  C S Walker; T Sundrum; D L Hay
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.

Authors:  Sihoon Lee; Michael Mannstadt; Jun Guo; Seul Min Kim; Hyon-Seung Yi; Ashok Khatri; Thomas Dean; Makoto Okazaki; Thomas J Gardella; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-06-08       Impact factor: 6.741

4.  Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor.

Authors:  Andrea Kirkpatrick; Jiyoung Heo; Ravinder Abrol; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

Review 5.  International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors.

Authors:  Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

6.  The VPAC1 receptor: structure and function of a class B GPCR prototype.

Authors:  A Couvineau; E Ceraudo; Y-V Tan; P Nicole; M Laburthe
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-16       Impact factor: 5.555

7.  Functional characterization and evolution of PTH/PTHrP receptors: insights from the chicken.

Authors:  Pedro L C Pinheiro; João C R Cardoso; Deborah M Power; Adelino V M Canário
Journal:  BMC Evol Biol       Date:  2012-07-06       Impact factor: 3.260

8.  Conformational thermostabilisation of corticotropin releasing factor receptor 1.

Authors:  James Kean; Andrea Bortolato; Kaspar Hollenstein; Fiona H Marshall; Ali Jazayeri
Journal:  Sci Rep       Date:  2015-07-10       Impact factor: 4.379

9.  Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity.

Authors:  Janna Blechman; Gil Levkowitz
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-21       Impact factor: 5.555

10.  GRK5 intronic (CA)n polymorphisms associated with type 2 diabetes in Chinese Hainan Island.

Authors:  Zhenfang Xia; Tubao Yang; Zhuansuo Wang; Jianping Dong; Chunyan Liang
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.